Traws Pharma, Inc. Net Cash Provided by (Used in) Continuing Operations
Traws Pharma, Inc. (TRAW) reported Net Cash Provided by (Used in) Continuing Operations of -$9.88 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-05-15
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was -$9.88M.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was $1.23M.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$13.15M, a 151.71% decline year-over-year.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was $875.00K.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was -$16.43M.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for fiscal 2013 was -$21.52M, a 127.30% decline from fiscal 2012.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for fiscal 2012 was $78.81M.
- Traws Pharma, Inc. net cash provided by (used in) continuing operations for fiscal 2011 was -$4.63M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-03-31 | -$9.88M 10-Q · filed 2015-05-15 | -$8.65M derived: sum of 2 quarters · filed 2015-05-15 | -$21.80M derived: sum of 3 quarters · filed 2015-05-15 | -$20.93M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$11.92M derived: sum of 2 quarters · filed 2015-03-30 | -$11.04M derived: sum of 3 quarters · filed 2015-03-30 | -$16.43M 10-K · filed 2015-03-30 |
| 2014-09-30 | -$13.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$12.28M derived: sum of 2 quarters · filed 2014-11-14 | -$17.66M 10-Q · filed 2014-11-14 | -$34.26M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-06-30 | $875.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$4.51M 10-Q · filed 2014-08-14 | -$21.11M derived: sum of 3 quarters · filed 2015-05-15 | $4.32M derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-03-31 | -$5.38M 10-Q · filed 2015-05-15 | -$21.99M derived: sum of 2 quarters · filed 2015-05-15 | $3.44M derived: sum of 3 quarters · filed 2015-05-15 | -$12.68M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $8.83M derived: sum of 2 quarters · filed 2015-03-30 | -$7.30M derived: sum of 3 quarters · filed 2015-03-30 | -$21.52M 10-K · filed 2015-03-30 |
| 2013-09-30 | $25.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $9.30M derived: sum of 2 quarters · filed 2014-11-14 | -$4.92M 10-Q · filed 2014-11-14 | -$31.54M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | -$16.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$30.35M 10-Q · filed 2014-08-14 | -$56.97M derived: sum of 3 quarters · filed 2015-03-30 | $48.66M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | -$14.22M 10-Q · filed 2014-05-15 | -$40.84M derived: sum of 2 quarters · filed 2015-03-30 | $64.78M derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | -$26.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $79.00M derived: sum of 2 quarters · filed 2015-03-30 | $78.81M 10-K · filed 2015-03-30 | |
| 2012-09-30 | $105.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $105.44M 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | -$191.00K 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | -$4.63M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |